IIPR vs REFI
IIPR: A specialized REIT that provides real estate capital to the regulated cannabis industry via sale-leaseback transactions while expanding into life science investments. REFI: A specialized mortgage REIT providing senior loan financing to state-licensed cannabis operators in the U.S.
Side-by-side fundamentals
| Metric | IIPR | REFI | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $52.77 | $9.08 | |
| Market cap | $1.5B | $233M | |
| P/E as of 2026-10-20 | 11.94 | 6.68 | REFI lower |
| Net margin | +44.5% | +66.1% | REFI higher |
| Operating margin FY2025, SEC XBRL | +46.7% | n/a | |
| ROE FY2025, SEC XBRL | +6.4% | +11.7% | REFI higher |
| ROA FY2025, SEC XBRL | +5.0% | +8.5% | REFI higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | n/a | 0.16 | |
| Revenue growth (YoY) FY2025, SEC XBRL | -13.8% | n/a | |
| Revenue CAGR (3y) SEC XBRL | -1.3% | n/a | |
| Dividend yield as of 2026-09-02 | +13.7% | +17.1% | REFI higher |
| Dividend streak (yrs) SEC XBRL | 5 | 1 | IIPR higher |
| Beta as of 2026-09-02 | 0.66 | 0.39 | |
| 1-year return as of 2026-10-20 close | -3.4% | -31.2% | IIPR higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.